In summary, our data indicate that APOE influences Alzheimer’s disease neuropathology via two independent pathways, one where β-amyloid accumulation correlates with the development of tauopathy (NFTs), and a second pathway with direct effects on NFTs independent of β-amyloidosis. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.